769 related articles for article (PubMed ID: 6439269)
1. Triggering by Paf-acether and adrenaline of cyclo-oxygenase-independent platelet aggregation.
Fouque F; Vargaftig BB
Br J Pharmacol; 1984 Nov; 83(3):625-33. PubMed ID: 6439269
[TBL] [Abstract][Full Text] [Related]
2. Potentiation and inhibition by clonidine of PAF-acether-induced human platelet activation.
Fouque F; Vargaftig BB
Eur J Pharmacol; 1987 Mar; 135(2):211-8. PubMed ID: 3582495
[TBL] [Abstract][Full Text] [Related]
3. Adrenaline and PAF-acether synergize to trigger cyclooxygenase-independent activation of plasma-free human platelets.
Vargaftig BB; Fouque F; Benveniste J; Odiot J
Thromb Res; 1982 Nov; 28(4):557-73. PubMed ID: 7164036
[TBL] [Abstract][Full Text] [Related]
4. Human platelet aggregation and release reaction induced by platelet activating factor (PAF-acether)--effects of acetylsalicylic acid and external ionized calcium.
Cattaneo M; Canciani MT; Mannucci PM
Thromb Haemost; 1985 Apr; 53(2):221-4. PubMed ID: 3927505
[TBL] [Abstract][Full Text] [Related]
5. Platelet-activating factor (PAF-acether): thromboxane-independent synergism with adrenaline on human platelets and recent insights into its mode of action.
Fouque F; Joseph D; Vargaftig BB
Agents Actions; 1982 Dec; 12(5-6):720-2. PubMed ID: 7164947
[TBL] [Abstract][Full Text] [Related]
6. Antagonists of PAF-acether do not suppress thrombin-induced aggregation of ADP-deprived and aspirin-treated human platelets.
Adnot S; Joseph D; Vargaftig BB
Agents Actions; 1987 Jun; 21(1-2):195-202. PubMed ID: 3115070
[TBL] [Abstract][Full Text] [Related]
7. Degranulation of rabbit platelets with PAF-acether: a new procedure for unravelling the mode of action of platelet-activating substances.
Vargaftig BB; Joseph D; Marlas G; Chevance LG
Thromb Haemost; 1982 Aug; 48(1):67-71. PubMed ID: 7135345
[TBL] [Abstract][Full Text] [Related]
8. Cooperative effects of 1-O-alkyl-2-O-acetyl-sn-glycero-3-phosphocholine (PAF-acether) and exogenous arachidonic acid in stimulation of human blood platelets.
Ostermann G; Till U; Thielmann K
Thromb Res; 1984 Feb; 33(4):409-18. PubMed ID: 6710440
[TBL] [Abstract][Full Text] [Related]
9. Adrenaline/PAF acether synergism on human platelets: involvement of Hydergine.
Fouque F; Vargaftig BB
J Pharmacol; 1985; 16 Suppl 3():129-34. PubMed ID: 4094442
[TBL] [Abstract][Full Text] [Related]
10. Synergistic actions of PAF-acether and sodium arachidonate in human platelet aggregation. 1. Studies in normal human platelet rich plasma.
Altman R; Scazziota A; Rouvier J; Cacchione R
Thromb Res; 1986 Jul; 43(1):103-11. PubMed ID: 3014677
[TBL] [Abstract][Full Text] [Related]
11. Dissociation between inhibition of phospholipid methylation and production of PAF-acether by rabbit platelets.
Touqui L; Chignard M; Jacquemin C; Wal F; Vargaftig BB
Experientia; 1984 Apr; 40(4):374-7. PubMed ID: 6714369
[TBL] [Abstract][Full Text] [Related]
12. PAF-acether may not mediate the third pathway of platelet aggregation since self-desensitization reduces the effects of low thrombin but enhances those of convulxin.
Wal F; Joseph D; Touqui L; Vargaftig BB
Thromb Haemost; 1985 Feb; 53(1):99-104. PubMed ID: 3992525
[TBL] [Abstract][Full Text] [Related]
13. Platelet-activating factor (PAF-acether) secretion from platelets: effect of aggregating agents.
Chignard M; Le Couedic JP; Vargaftig BB; Benveniste J
Br J Haematol; 1980 Nov; 46(3):455-64. PubMed ID: 6778498
[TBL] [Abstract][Full Text] [Related]
14. The platelet-independent release of thromboxane A2 by Paf-acether from guinea-pig lungs involves mechanisms distinct from those for leukotriene.
Lefort J; Rotilio D; Vargaftig BB
Br J Pharmacol; 1984 Jul; 82(3):565-75. PubMed ID: 6430375
[TBL] [Abstract][Full Text] [Related]
15. Potentiation by adrenaline of human platelet activation and the inhibition by the alpha-adrenergic antagonist nicergoline of platelet adhesion, secretion and aggregation.
Lanza F; Cazenave JP; Beretz A; Sutter-Bay A; Kretz JG; Kieny R
Agents Actions; 1986 Aug; 18(5-6):586-95. PubMed ID: 3020942
[TBL] [Abstract][Full Text] [Related]
16. Synergistic actions of paf-acether and sodium arachidonate in human platelet aggregation. 2. Unexpected results after aspirin intake.
Altman R; Scazziota A
Thromb Res; 1986 Jul; 43(1):113-20. PubMed ID: 3088757
[TBL] [Abstract][Full Text] [Related]
17. 1-O-alkyl-2-acyl-sn-glycero-3-phosphorylcholine is the precursor of platelet-activating factor in stimulated rabbit platelets. Evidence for an alkylacetyl-glycerophosphorylcholine cycle.
Touqui L; Jacquemin C; Dumarey C; Vargaftig BB
Biochim Biophys Acta; 1985 Jan; 833(1):111-8. PubMed ID: 3967037
[TBL] [Abstract][Full Text] [Related]
18. Selective inhibition of adrenaline-induced human platelet aggregation by the structurally related Paf antagonist Ro 19-3704.
Schattner M; Parini A; Fouque F; Vargaftig BB; Touqui L
Br J Pharmacol; 1989 Apr; 96(4):759-66. PubMed ID: 2787179
[TBL] [Abstract][Full Text] [Related]
19. Contribution of ADP to the amplification of primary platelet aggregation by platelet activating factor (PAF): modulatory role of aspirin.
Lauri D; Cerletti C; de Gaetano G
Agents Actions; 1986 Mar; 17(5-6):506-11. PubMed ID: 3706054
[TBL] [Abstract][Full Text] [Related]
20. Specific inhibition of PAF-acether-induced platelet activation by BN 52021 and comparison with the PAF-acether inhibitors kadsurenone and CV 3988.
Nunez D; Chignard M; Korth R; Le Couedic JP; Norel X; Spinnewyn B; Braquet P; Benveniste J
Eur J Pharmacol; 1986 Apr; 123(2):197-205. PubMed ID: 3086108
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]